Figure 2
Figure 2. Loss of Gas6 conferred protection from lethal acute GVHD. Bone marrow isolated from donor mice was T cell–depleted. Each lethally irradiated recipient mouse (Balb/C, H-2d) with a wild-type (WT) or Gas6−/− genotype received 5 × 106 T cell–depleted BMCs from a pool of full MHC-mismatched WT donors (C57BL/6, H-2b). We infused 0.5 × 106 WT splenic donor T cells to WT or Gas6−/− recipient mice. (A) Kaplan-Meier plots of the survival of WT and Gas6−/− mice. Survival after lethal acute graft-versus-host disease (GVHD) was improved in Gas6−/− mice compared with WT mice (log-rank test, n = 10 and 13, respectively, P > .017). (B) Clinical signs of GVHD scored daily after transplantation according to Cooke et al.19 A score of 3 was assigned to mice that died in the course of the experiment. Two-way analysis of variance for repeated measures; n = 13 for WT and 10 for Gas6−/−, P = .012; followed by Bonferroni post tests for specific time points, **P < .01, ***P < .001.

Loss of Gas6 conferred protection from lethal acute GVHD. Bone marrow isolated from donor mice was T cell–depleted. Each lethally irradiated recipient mouse (Balb/C, H-2d) with a wild-type (WT) or Gas6−/− genotype received 5 × 106 T cell–depleted BMCs from a pool of full MHC-mismatched WT donors (C57BL/6, H-2b). We infused 0.5 × 106 WT splenic donor T cells to WT or Gas6−/− recipient mice. (A) Kaplan-Meier plots of the survival of WT and Gas6−/− mice. Survival after lethal acute graft-versus-host disease (GVHD) was improved in Gas6−/− mice compared with WT mice (log-rank test, n = 10 and 13, respectively, P > .017). (B) Clinical signs of GVHD scored daily after transplantation according to Cooke et al.19  A score of 3 was assigned to mice that died in the course of the experiment. Two-way analysis of variance for repeated measures; n = 13 for WT and 10 for Gas6−/−, P = .012; followed by Bonferroni post tests for specific time points, **P < .01, ***P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal